Craig Wheeler
Director/Board Member chez AMICUS THERAPEUTICS, INC.
Fortune : 616 919 $ au 31/03/2024
Profil
Craig A. Wheeler est un homme d'affaires qui a été à la tête de 5 entreprises différentes et qui siège au conseil d'administration d'Amicus Therapeutics, Inc. Dans le passé, il a occupé le poste de membre principal - pratique des soins de santé au Boston Consulting Group, Inc. et a été président d'Avanir Pharmaceuticals, Inc. et président, chef de la direction et directeur de Momenta Pharmaceuticals, Inc. ainsi que président de Chiron Corp. et de CHIRON Biopharmaceuticals, président de l'Association for Accessible Medicines et membre du Whitehead Institute for Biomedical Research. M. Wheeler a obtenu un diplôme d'études supérieures et un diplôme de premier cycle de l'université Cornell et un MBA de la Wharton School de l'université de Pennsylvanie.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/06/2023 | 52 370 ( 0,02% ) | 616 919 $ | 31/03/2024 |
Postes actifs de Craig Wheeler
| Sociétés | Poste | Début |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Director/Board Member | 10/06/2016 |
| Headwaters Biotech Advisors LLC | Chief Executive Officer | - |
Anciens postes connus de Craig Wheeler
| Sociétés | Poste | Fin |
|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Chief Executive Officer | 01/10/2020 |
Association for Accessible Medicines
 Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Chairman | 22/02/2016 |
| GEORGIA PUBLIC HEALTH ASSOCIATION, INC. | Chairman | 01/02/2016 |
| AVANIR PHARMACEUTICALS INC | Chairman | 13/01/2015 |
| CHIRON Biopharmaceuticals | President | 01/06/2006 |
Formation de Craig Wheeler
| Cornell University | Graduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AMICUS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Commercial Services |
Whitehead Institute for Biomedical Research
 Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Commercial Services |
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Commercial Services |
| CHIRON Biopharmaceuticals | |
| Headwaters Biotech Advisors LLC | |
| GEORGIA PUBLIC HEALTH ASSOCIATION, INC. |
